Hippocratic AI announced a global collaboration with Boston Consulting Group to deploy generative AI healthcare agents across biopharma and medtech organizations. The partnership combines Hippocratic AI’s safety-focused, regulated-use AI agents with BCG’s strategic and operational expertise, aiming to move life sciences companies beyond isolated AI pilots toward enterprise-wide adoption that delivers measurable value.
Under the collaboration, Hippocratic AI will provide non-diagnostic, patient-facing generative AI agents built on its Polaris Constellation architecture, which have supported more than 150 million clinical interactions across healthcare. These agents are designed to support activities such as patient onboarding, adherence engagement, post-market monitoring, and clinical trial support, while BCG contributes C-suite advisory capabilities and AI transformation programs through BCG X to help organizations modernize commercial models and operational workflows in highly regulated life sciences environments.